StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$104.84+2.74 (+2.68%)

Close on Nov 19, 2026Market cap $4.68BP/E –Yield –

Grail net income

Net income is the profit left for shareholders after every expense, interest and tax.

Grail's net income for the twelve months ending Jun 30, 2026 was -$391.59M. For fiscal 2025 it was -$408.35M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$408.35M–
FY2024Dec 31, 2024-$2.03B–
FY2023Dec 31, 2023-$1.47B–
FY2022Jan 1, 2023-$5.40B–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$110.25M–
Q1 FY2026Mar 31, 2026-$93.19M–
Q4 FY2025Dec 31, 2025-$99.18M–
Q3 FY2025Sep 30, 2025-$88.98M–
Q2 FY2025Jun 30, 2025-$113.99M–
Q1 FY2025Mar 31, 2025-$106.21M–
Q4 FY2024Dec 31, 2024-$97.07M–
Q3 FY2024Sep 30, 2024-$125.69M–
Q2 FY2024Jun 30, 2024-$1.59B–
Q1 FY2024Mar 31, 2024-$218.91M–
Q4 FY2023Dec 31, 2023-$187.53M–
Q3 FY2023Oct 1, 2023-$891.45M–
Q2 FY2023Jun 30, 2023-$193.05M–
Q1 FY2023Apr 2, 2023-$193.67M–

More Grail figures

See a number that looks wrong?